MMIT - Managed Markets Insight & Technology

  • Home
  • MMIT - Managed Markets Insight & Technology

MMIT - Managed Markets Insight & Technology We leverage technology, research and industry experts to make sense of how and why specific pharmaceutical drugs are covered.

01/05/2026

Free-text plan names are like junk drawers. You can dig through them… but wouldn’t you rather know exactly what’s inside?

With MMIT’s BIN/PCN/Group mapping, you gain structure, clarity, and confidence in coverage insights.

Meet with MMIT to learn more. Because guessing isn’t a strategy. https://vist.ly/42k9t

Many long-anticipated policy reforms will take effect this year, resulting in real commercial impacts for pharma manufac...
01/05/2026

Many long-anticipated policy reforms will take effect this year, resulting in real commercial impacts for pharma manufacturers. As policy pressures intensify, specialty drug pricing is becoming a systemic access challenge.

On May 7, join The Dedham Group’s Hannah Baxter and MMIT’s Andrew Rouff as they talk through the results of our 2026 State of Patient Access survey. They’ll explore how pharma brands are rethinking strategies and developing AI and RWD capabilities to troubleshoot access challenges.

Register today: https://vist.ly/42jwa?

01/05/2026

Not all early-detection tests are viewed equally by payers. https://vist.ly/42jhp

According to research highlighted by MMIT’s Mugdha Natekar, coverage varies widely by tumor type, with routine screenings well covered and rarer cancers facing steep access gaps.

See which cancers are prioritized today and which may gain coverage next by clicking the link in this post.

30/04/2026

X — the collab we've all been waiting for!

First Citeline, now us! We can't wait to be part of so many incredible events this year. Stay tuned to see who from Norstella takes over next!

30/04/2026

And that’s a wrap! Another Asembia in the books. Over 400 meetings, a speaking session, and countless memories and meaningful conversations.

Thanks for following along as I took over the MMIT account. I truly had a blast and cannot wait to keep the conversations going when I get home.

See you next time, Vegas!

29/04/2026

We’re almost at the end of and every year my team exceeds my expectations. In just three days, they have conducted over 400 meetings with organizations across healthcare helping them answer their top business questions.

I must give a HUGE shoutout to our SDRs, who help our team coordinate these meetings and get people where they need to be (which means a LOT of walking). I asked them to share their step counts…let’s see where they ended up.

There is so much happening in the exhibit hall, I had to go explore! When our colleagues at Citeline attended SCOPE ea...
29/04/2026

There is so much happening in the exhibit hall, I had to go explore!

When our colleagues at Citeline attended SCOPE earlier this year, they were looking for puppies. Turns out Asembia is where to find them! Sorry Nathalie! I’ll let them know you say hi!

29/04/2026

Time for day three of !

We’re heading into the final day of the conference ready to share how MMIT can help answer your top market access question to make more confident decisions.

There’s still time to get a demo of our solutions or connect with our team! Stop by booth 1415.

29/04/2026

That’s the end of day two! So many great conversations at our booth and great insights were shared today. Only one more day to go!

Looking forward to taking a break before the action tomorrow. If you need me, you know where to find me!

28/04/2026

What’s keeping pharma execs up at night in 2026? MMIT’s Andrew Rouff and The Dedham Group’s Hannah Baxter just shared insight into key pharma pain points during their presentation, “The State of Patient Access 2026.” I caught up with them after the session to get their thoughts. Hear what they had to say.

Congrats on a great session!

Think you know MMIT? There’s so much more to learn. Come chat with my colleague, Liz, about our new, AI-led market acces...
28/04/2026

Think you know MMIT? There’s so much more to learn. Come chat with my colleague, Liz, about our new, AI-led market access solutions. You can also watch demos of our innovative products. Stop by booth 1415!

And we’re back! Day two of is underway and it’s going to be a busy day: • Live demos at our booth• The State of Patien...
28/04/2026

And we’re back! Day two of is underway and it’s going to be a busy day:

• Live demos at our booth
• The State of Patient Access 2026 presentation
• Meetings, meetings, and more meetings

Come see us at booth 1415 throughout the conference to see how we’re helping organizations make more confident market access decisions.

Address


Telephone

+12677513162

Website

Alerts

Be the first to know and let us send you an email when MMIT - Managed Markets Insight & Technology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to MMIT - Managed Markets Insight & Technology:

Shortcuts

  • Want your practice to be the top-listed Clinic?

Share

Solving the What and the Why of Market Access

We leverage technology, research and industry experts to make sense of how and why specific pharmaceutical drugs are covered. Physicians and pharmacies use our data and applications to understand what drugs are available to patients and how they are covered by health plans. Pharmaceutical manufacturers trust our data to understand how their drug and competitive drugs are covered, which helps forecast performance and tune strategy.